[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201615829D0 - Antibacterial compounds - Google Patents

Antibacterial compounds

Info

Publication number
GB201615829D0
GB201615829D0 GBGB1615829.7A GB201615829A GB201615829D0 GB 201615829 D0 GB201615829 D0 GB 201615829D0 GB 201615829 A GB201615829 A GB 201615829A GB 201615829 D0 GB201615829 D0 GB 201615829D0
Authority
GB
United Kingdom
Prior art keywords
antibacterial compounds
antibacterial
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1615829.7A
Other versions
GB2547740A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redx Pharna PLC
Original Assignee
Redx Pharna PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharna PLC filed Critical Redx Pharna PLC
Publication of GB201615829D0 publication Critical patent/GB201615829D0/en
Publication of GB2547740A publication Critical patent/GB2547740A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1615829.7A 2015-09-18 2016-09-16 Antibacterial compounds Withdrawn GB2547740A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1516616.8A GB201516616D0 (en) 2015-09-18 2015-09-18 Antibacterial compounds

Publications (2)

Publication Number Publication Date
GB201615829D0 true GB201615829D0 (en) 2016-11-02
GB2547740A GB2547740A (en) 2017-08-30

Family

ID=54544499

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1516616.8A Ceased GB201516616D0 (en) 2015-09-18 2015-09-18 Antibacterial compounds
GB1615829.7A Withdrawn GB2547740A (en) 2015-09-18 2016-09-16 Antibacterial compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1516616.8A Ceased GB201516616D0 (en) 2015-09-18 2015-09-18 Antibacterial compounds

Country Status (1)

Country Link
GB (2) GB201516616D0 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146599A1 (en) * 1981-11-25 1983-07-07 Basf Ag, 6700 Ludwigshafen NEW TRIAZOLOCHINAZOLINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
TW200508233A (en) * 2003-05-29 2005-03-01 Millennium Pharm Inc Chk-1 inhibitors
JP2006045118A (en) * 2004-08-04 2006-02-16 Mochida Pharmaceut Co Ltd New pyrazoloquinolone derivative
US20100168084A1 (en) * 2008-05-08 2010-07-01 Huber L Julie Therapeutic compounds and related methods of use
ES2527188T3 (en) * 2011-09-26 2015-01-21 Sanofi Pirazolquinolinone derivatives, their preparation and therapeutic use
US9012466B2 (en) * 2013-03-12 2015-04-21 Arqule Inc. Substituted tricyclic pyrazolo-pyrimidine compounds
GB201406486D0 (en) * 2014-04-10 2014-05-28 Redx Pharma Ltd Antibacterial compounds

Also Published As

Publication number Publication date
GB201516616D0 (en) 2015-11-04
GB2547740A (en) 2017-08-30

Similar Documents

Publication Publication Date Title
HK1254677A1 (en) Antibacterial compounds
IL263283A (en) New antibacterial compounds
ZA201606715B (en) Antibacterial compounds
IL274229A (en) Antibacterial compounds
GB201516614D0 (en) Antibacterial compounds
GB201711555D0 (en) Antibacterial compounds
GB201704166D0 (en) Antibacterial Compounds
GB201602235D0 (en) Antibacterial compounds
GB201615829D0 (en) Antibacterial compounds
GB201616460D0 (en) Antibacterial compounds
GB201616456D0 (en) Antibacterial compounds
GB201613866D0 (en) Antibacterial compounds
GB201519208D0 (en) Antibacterial Compounds
GB201516611D0 (en) Antibacterial compounds
GB201516613D0 (en) Antibacterial compounds
PT3316969T (en) Antibacterial compounds
GB201704313D0 (en) Antibacterial compounds
GB201509006D0 (en) Antibacterial compounds
GB201602234D0 (en) Antibacterial compounds
GB201602241D0 (en) Antibacterial compounds
GB201517221D0 (en) New uses for antibacterial compounds
GB201503460D0 (en) New uses for antibacterial compounds
GB201417939D0 (en) Antibacterial compounds
GB201417941D0 (en) Antibacterial compounds
GB201414205D0 (en) Antibacterial compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)